{
  "metadata": {
    "input_documents": [
      "research_paper_1.pdf",
      "research_paper_2.pdf", 
      "research_paper_3.pdf",
      "research_paper_4.pdf"
    ],
    "persona": "PhD Researcher in Computational Biology",
    "job_to_be_done": "Prepare a comprehensive literature review focusing on methodologies, datasets, and performance benchmarks",
    "processing_timestamp": "2025-07-23T10:30:45Z"
  },
  "extracted_sections": [
    {
      "document": "research_paper_1.pdf",
      "page_number": 3,
      "section_title": "Graph Neural Network Architecture for Drug Discovery",
      "importance_rank": 1,
      "relevance_score": 0.95,
      "content_preview": "We propose a novel GNN architecture specifically designed for molecular property prediction..."
    },
    {
      "document": "research_paper_2.pdf", 
      "page_number": 5,
      "section_title": "Benchmark Datasets and Evaluation Metrics",
      "importance_rank": 2,
      "relevance_score": 0.92,
      "content_preview": "Our evaluation encompasses three primary datasets: ZINC, QM9, and DrugBank..."
    },
    {
      "document": "research_paper_3.pdf",
      "page_number": 2,
      "section_title": "Comparative Performance Analysis",
      "importance_rank": 3,
      "relevance_score": 0.89,
      "content_preview": "Performance benchmarks show significant improvements over traditional methods..."
    }
  ],
  "sub_section_analysis": [
    {
      "document": "research_paper_1.pdf",
      "section_title": "Graph Neural Network Architecture for Drug Discovery",
      "refined_text": "The proposed architecture combines molecular graph representations with attention mechanisms to capture both local and global molecular features. Key innovations include: 1) Multi-scale graph convolutions for hierarchical feature extraction, 2) Attention-based pooling for molecular property aggregation, 3) Residual connections to prevent gradient vanishing in deep networks.",
      "page_number": 3,
      "key_concepts": ["graph convolutions", "attention mechanisms", "molecular features"],
      "methodology_relevance": 0.96
    },
    {
      "document": "research_paper_2.pdf",
      "section_title": "Benchmark Datasets and Evaluation Metrics", 
      "refined_text": "Comprehensive evaluation protocol using standardized datasets: ZINC (250K compounds), QM9 (134K small organic molecules), DrugBank (13K approved drugs). Metrics include RMSE for regression tasks, ROC-AUC for classification, and computational efficiency measured in training time and memory usage.",
      "page_number": 5,
      "key_concepts": ["ZINC dataset", "QM9", "DrugBank", "evaluation metrics"],
      "methodology_relevance": 0.93
    }
  ],
  "processing_stats": {
    "total_documents_processed": 4,
    "total_sections_extracted": 12,
    "processing_time_seconds": 45.2,
    "model_memory_usage_mb": 892
  }
}
